A2DMQY Cronos Group Inc

Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders

Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders

TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, approximately 98.6% of shareholders voting in person or by proxy approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2024 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration.

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at and the Company’s Form 8-K filed on EDGAR at /edgar.

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

For further information, please contact:

Shayne Laidlaw

Investor Relations

Tel: (416) 504-0004

 



EN
22/07/2024

Underlying

A2DMQYCronos Group Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Reports 2025 Second Quarter Results

Cronos Group Reports 2025 Second Quarter Results Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 second quarter business results. "Cronos delivered another quarter of str...

August 7, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call...

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025 TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 second quarter earnings conference call on Thursday, August 7, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage partic...

July 25, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Grows its International Footprint in Switzerland

Cronos Grows its International Footprint in Switzerland TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training. “We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, ...

July 2, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Sharehol...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was...

June 23, 2025 1 EN
 PRESS RELEASE
Free
A2DMQY Cronos Group In...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Co...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company...

June 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch